QINLOCK
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
73207-101 -
Package NDC
73207-101-30 -
Package NDC
73207-101-31 -
Application number
NDA213973 -
SPL ID
142c8672-a552-4d20-9226-2a92aa9773d1 -
SPL set ID
9f18e462-03dd-4296-a02a-a0577e3ee78d -
UNII
9XW757O13D -
RxCUI
2369397 -
RxCUI
2369403
What the source publishes
- Labeler
- Deciphera Pharmaceuticals, LLC
- Active ingredients
- Ripretinib
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "QINLOCK",
"splId": "142c8672-a552-4d20-9226-2a92aa9773d1",
"labels": [
{
"setId": "9f18e462-03dd-4296-a02a-a0577e3ee78d",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9f18e462-03dd-4296-a02a-a0577e3ee78d",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9f18e462-03dd-4296-a02a-a0577e3ee78d"
}
],
"routes": [
"ORAL"
],
"labeler": "Deciphera Pharmaceuticals, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 BOTTLE in 1 CARTON (73207-101-30) / 90 TABLET in 1 BOTTLE",
"package_ndc": "73207-101-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20200515"
},
{
"sample": true,
"description": "1 BOTTLE in 1 CARTON (73207-101-31) / 30 TABLET in 1 BOTTLE",
"package_ndc": "73207-101-31",
"identifierStatus": "well-formed",
"marketing_start_date": "20200515"
}
],
"productId": "73207-101_142c8672-a552-4d20-9226-2a92aa9773d1",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "73207-101",
"deaSchedule": null,
"genericName": "Ripretinib",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "RIPRETINIB",
"strength": "50 mg/1"
}
],
"applicationNumber": "NDA213973",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20200515",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175605",
"N0000020034",
"N0000020028",
"N0000187062",
"N0000185503",
"N0000190113"
],
"unii": [
"9XW757O13D"
],
"rxcui": [
"2369397",
"2369403"
],
"spl_set_id": [
"9f18e462-03dd-4296-a02a-a0577e3ee78d"
],
"pharm_class_epc": [
"Kinase Inhibitor [EPC]"
],
"pharm_class_moa": [
"Stem Cell Factor (KIT) Receptor Inhibitors [MoA]",
"Platelet-derived Growth Factor alpha Receptor Inhibitors [MoA]",
"Cytochrome P450 2C8 Inhibitors [MoA]",
"P-Glycoprotein Inhibitors [MoA]",
"Breast Cancer Resistance Protein Inhibitors [MoA]"
],
"manufacturer_name": [
"Deciphera Pharmaceuticals, LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:73207-101_142c8672-a552-4d20-9226-2a92aa9773d1"